|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: IDEC PHARMACEUTICALS CORP / DE, 10-Q, EX-10.11, 2000-08-14 |
Next: XL CAPITAL LTD, 10-Q, 2000-08-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONDENSED CONSOLIDATED BALANCE SHEETS AND CONDENSED CONSOLIDATED STATEMENTS OF
OPERATIONS FOR THE YEAR ENDED JUNE 30, 2000 CONTAINED IN THE COMPANY'S QUARTERLY
REPORT ON FORM 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS AND THE NOTES THERETO.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 111,983
<SECURITIES> 162,274
<RECEIVABLES> 1,534
<ALLOWANCES> 283
<INVENTORY> 778
<CURRENT-ASSETS> 313,579
<PP&E> 48,209
<DEPRECIATION> 22,776
<TOTAL-ASSETS> 352,133
<CURRENT-LIABILITIES> 19,315
<BONDS> 0
0
0
<COMMON> 22
<OTHER-SE> 197,740
<TOTAL-LIABILITY-AND-EQUITY> 352,133
<SALES> 0
<TOTAL-REVENUES> 62,787
<CGS> 0
<TOTAL-COSTS> 33,894
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 3,522
<INCOME-PRETAX> 20,481
<INCOME-TAX> 3,557
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 16,924
<EPS-BASIC> 0.38
<EPS-DILUTED> 0.32
</TABLE>
|
|